AU2001269388A1 - New processes for the production of fexofenadine - Google Patents

New processes for the production of fexofenadine

Info

Publication number
AU2001269388A1
AU2001269388A1 AU2001269388A AU6938801A AU2001269388A1 AU 2001269388 A1 AU2001269388 A1 AU 2001269388A1 AU 2001269388 A AU2001269388 A AU 2001269388A AU 6938801 A AU6938801 A AU 6938801A AU 2001269388 A1 AU2001269388 A1 AU 2001269388A1
Authority
AU
Australia
Prior art keywords
sub
compound
formula
fexofenadine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269388A
Inventor
Federico Junquera Milla
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texcontor
Original Assignee
Texcontor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texcontor filed Critical Texcontor
Publication of AU2001269388A1 publication Critical patent/AU2001269388A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/313—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Catalysts (AREA)

Abstract

An improved process for the manufacture of fexofenadine is described in which a compound of formula (F): wherein R<SUB>2 </SUB>represents COOH, COO-C<SUB>1-6 </SUB>alkyl or CN; and R<SUB>3 </SUB>represents hydrogen, mesylate, triflate, tosylate or carboxy-C<SUB>1-6</SUB>-alkyl, or a salt thereof is prepared by: (I) reacting a compound of formula (B): wherein R1 represents hydrogen or carboxy-C<SUB>1-6</SUB>-alkyl; and R<SUB>2 </SUB>is a hereinbefore defined, with a copper and/or silver compound in the presence of palladium or a compound thereof to yield a compound of formula (C): wherein R<SUB>1</SUB>, and R<SUB>2 </SUB>are as hereinbefore defined; (II) converting said compound of formula (C) into a compound of formula (E): wherein R<SUB>2 </SUB>and R<SUB>3 </SUB>are as hereinbefore defined and R<SUB>4 </SUB>represents a halogen atom, and (III) reacting said compound of formula (E) with azacyclonol.
AU2001269388A 2000-07-28 2001-07-19 New processes for the production of fexofenadine Abandoned AU2001269388A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0018691 2000-07-28
GBGB0018691.6A GB0018691D0 (en) 2000-07-28 2000-07-28 Process
PCT/IB2001/001294 WO2002010115A1 (en) 2000-07-28 2001-07-19 New processes for the production of fexofenadine

Publications (1)

Publication Number Publication Date
AU2001269388A1 true AU2001269388A1 (en) 2002-02-13

Family

ID=9896639

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269388A Abandoned AU2001269388A1 (en) 2000-07-28 2001-07-19 New processes for the production of fexofenadine

Country Status (9)

Country Link
US (1) US7176318B2 (en)
EP (1) EP1307423B1 (en)
AT (1) ATE389631T1 (en)
AU (1) AU2001269388A1 (en)
DE (1) DE60133288T2 (en)
ES (1) ES2302737T3 (en)
GB (1) GB0018691D0 (en)
PT (1) PT1307423E (en)
WO (1) WO2002010115A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700779B2 (en) 2001-06-18 2010-04-20 Dr. Reddy's Laboratories Limited Crystalline forms of fexofenadine and its hydrochloride
CN100390145C (en) * 2001-06-18 2008-05-28 雷迪实验室有限公司 Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-a, a-dimethylbenzene acetic acid and its hydrochloride
EP1616861A3 (en) * 2004-06-15 2006-02-08 Dipharma S.p.A. A process for the preparation of keto compounds
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
CN104402773A (en) 2008-02-12 2015-03-11 柳韩洋行 Process for preparation of 2-methyl-2'-phenylpropionic acid derivatives and novel intermediate compounds
CN102070490B (en) * 2009-11-21 2014-07-30 浙江华海药业股份有限公司 Method for preparing fexofenadine intermediate 2-(4-(4-maloyl) phenyl)-2-methylpropionitrile
CN102070512B (en) * 2009-11-21 2014-11-19 浙江华海药业股份有限公司 Synthesizing route and preparation method of high-purity fexofenadine and intermediate thereof
US20130237709A1 (en) * 2012-03-02 2013-09-12 Chemelectiva S.R.L. Intermediates useful for the synthesis of fexofenadine, processes for their preparation and for the preparation of fexofenadine
ITMI20120589A1 (en) * 2012-04-12 2013-10-13 Chemelectiva S R L USEFUL INTERMEDIATES FOR THE SYNTHESIS OF FEXOPHENADINE, PROCESS FOR THEIR PREPARATION AND FOR THE PREPARATION OF FEXOFENADINE
PL3247699T3 (en) 2015-01-22 2019-11-29 Sanofi Aventis Deutschland Process for the production of 2-[4-(cyclopropanecarbonyl)phenyl]-2-methyl-propanenitrile
DK3365327T3 (en) 2015-10-22 2020-02-24 Sanofi Aventis Deutschland PROCEDURE FOR MANUFACTURING FEXOFENADINE AND INTERMEDIATES USED IN THERE
CN107782804B (en) * 2016-08-25 2020-11-13 人福普克药业（武汉）有限公司 Method for detecting related substances in fexofenadine hydrochloride sample

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5499135A (en) * 1990-12-24 1996-03-12 Alcatel N.V. Optical amplifier
HU226559B1 (en) * 1993-06-24 2009-03-30 Amr Technology Process for the production of piperidine derivatives
CN1275916C (en) * 1993-06-25 2006-09-20 阿温蒂斯公司 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
IT1271417B (en) * 1993-10-15 1997-05-28 Erregierre Ind Chim COMPOUNDS WITH ANTIHISTAMIN ACTIVITY PROCEDURE FOR THEIR PREPERATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
JPH08237203A (en) * 1995-02-23 1996-09-13 Fujitsu Ltd Optical filter array, optical transmitter and optical transmission system
US6101200A (en) * 1997-12-24 2000-08-08 Nortel Networks Corporation Laser module allowing simultaneous wavelength and power control
US6134253A (en) * 1998-02-19 2000-10-17 Jds Uniphase Corporation Method and apparatus for monitoring and control of laser emission wavelength
FR2776302B1 (en) * 1998-03-19 2002-04-12 Hoechst Marion Roussel Inc NEW PROCESS FOR THE PREPARATION OF FEXOFENADINE
JP3197869B2 (en) * 1998-03-31 2001-08-13 アンリツ株式会社 Tunable laser light source device
US6018536A (en) * 1998-11-20 2000-01-25 Sarnoff Corporation Multiple-wavelength mode-locked laser

Also Published As

Publication number Publication date
EP1307423A1 (en) 2003-05-07
WO2002010115A1 (en) 2002-02-07
DE60133288T2 (en) 2009-04-16
ATE389631T1 (en) 2008-04-15
GB0018691D0 (en) 2000-09-20
DE60133288D1 (en) 2008-04-30
US20030166682A1 (en) 2003-09-04
PT1307423E (en) 2008-06-09
US7176318B2 (en) 2007-02-13
EP1307423B1 (en) 2008-03-19
ES2302737T3 (en) 2008-08-01

Similar Documents

Publication Publication Date Title
AU2001269388A1 (en) New processes for the production of fexofenadine
SI1781683T1 (en) Process for the preparation of 17-vinyl- triflates as intermediates
HK1068877A1 (en) Process for the production of beraprost and its salts
CA2289409A1 (en) Sulfoxide compounds and acetone complexes, and a process for producing the same
RS50287B (en) Method for the preparation of citalopram
CY1111277T1 (en) KILOSTAZOL PRODUCTION METHOD
NO982712L (en) Methods and intermediates for the preparation of 1-benzyl-4 - ((5,6-dimethoxy-1-indanone) -2-yl) methylpiperidine
AU2003242144A1 (en) Processes for producing epoxytriazole derivative and intermediate therefor
CA2376540A1 (en) Process for preparing amlodipine benzenesulphonate
EP1484301A4 (en) PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
EA200801332A1 (en) METHOD FOR OBTAINING CARBOXANEALES
NO20053712L (en) Process for the preparation of substituted imidazole derivatives and intermediates used in the process
JO2433B1 (en) Process for the preparation of heterocyclic indene analogs
ZA200208986B (en) Process for the preparation of pesticidal compounds.
ZA200300598B (en) Production method of an ether compound.
EP1319646A4 (en) Process for preparation of 3,5-bisalkylphenols
IL158530A0 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
CA2384925A1 (en) Process for the preparation of oxazole derivatives
CA2485542A1 (en) Process for production of phenoxy-substituted 2-pyridone compounds
CY1108903T1 (en) PROCEDURE FOR PRODUCING SUBSTITUTED NICOTINIC ACID
AP2000001960A0 (en) Process for the preparation of pyrazole(4,3-d)pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof.